I now have comprehensive content from two authoritative sources. Let me compile the full answer.
Acute Rheumatic Fever (ARF)
Acute rheumatic fever is a delayed, non-suppurative inflammatory complication of Group A Streptococcus (GAS) pharyngitis. It is called "rheumatic" because it principally affects the joints and heart, and "fever" because fever is nearly universal. It does NOT follow streptococcal skin infections (impetigo).
Epidemiology
- Most common in children aged 5-15 years (rare before age 3, infrequent after 15)
- Occurs equally in males and females; however, rheumatic heart disease (the chronic sequela) is more common in women
- ARF develops in approximately 1.6-2.5% of patients with streptococcal pharyngitis
- Peak prevalence of rheumatic heart disease is in the 3rd and 4th decades (due to recurrent damage)
- More common in developing countries and overcrowded settings
Pathobiology (Molecular Mimicry)
The mechanism is not direct infection but an aberrant immune response:
| Manifestation | Mechanism |
|---|
| Carditis | Antibody-binding + T-cell infiltration of the heart |
| Arthritis | Immune complex deposition in joints |
| Chorea | Antibody binding to basal ganglia |
| Skin lesions | Delayed hypersensitivity reactions |
Structural similarities between GAS proteins (particularly M protein) and human cardiac proteins trigger cross-reactive antibodies and T cells - "molecular mimicry."
Clinical Manifestations
Symptoms begin approximately 2-3 weeks after GAS pharyngitis (average 18.6 days). Chorea may be delayed 4-8 weeks. Symptoms typically persist 2-4 weeks.
Major Manifestations (Mnemonic: JONES)
| Feature | Frequency | Notes |
|---|
| Joints (migratory polyarthritis) | ~75% | Most common; additive pattern also occurs; knees (76%), ankles (50%), elbows/wrists |
| O (cardiOtis) | 15-91% | Pancarditis; mitral valve most affected; Carey-Coombs murmur, mitral regurgitation |
| Nodules (subcutaneous) | <10% | 0.5-2 cm, painless, over bony prominences/extensor tendons |
| Erythema marginatum | <10% | Pink, non-pruritic, blanching, serpiginous pattern on trunk and proximal limbs |
| Sydenham's chorea | ~30% | Involuntary, non-rhythmic, purposeless movements; worse on one side; stops during sleep |
Fever is present in >90% of cases.
Carditis Details
- Affects all layers: pericardium, myocardium, endocardium (pancarditis)
- Mitral valve affected in almost all cases of carditis
- Aortic valve involved in ~20-30%
- Classic murmurs:
- Mitral regurgitation: high-pitched, blowing, holosystolic, apical
- Carey-Coombs murmur: low-pitched, apical, mid-diastolic flow murmur
- Aortic regurgitation: high-pitched, decrescendo, diastolic
- Heart failure is the most life-threatening feature
- Subclinical carditis can be detected by echocardiography (Doppler) even without audible murmur
Diagnosis - Revised Jones Criteria (2015 AHA)
There is no definitive test - it is a diagnosis of exclusion. Diagnosis requires evidence of preceding GAS infection PLUS fulfillment of the Jones criteria.
Evidence of preceding GAS infection:
- Positive throat culture or rapid strep test
- Elevated/rising ASO (anti-streptolysin O) or anti-DNase B titers
For Initial ARF:
- 2 major criteria, OR
- 1 major + 2 minor criteria
For Recurrent ARF:
- 2 major, OR 1 major + 2 minor, OR 3 minor criteria
| Criteria | Low-Risk Populations | Moderate/High-Risk Populations |
|---|
| Major | Carditis (clinical/echocardiographic), polyarticular arthritis, chorea, erythema marginatum, subcutaneous nodules | Same + monoarticular arthritis counts |
| Minor | Polyarthralgia, fever ≥38.5°C, ESR ≥60 mm and/or CRP ≥3.0 mg/dL, prolonged PR interval | Monoarthralgia, fever ≥38.5°C, ESR ≥30 mm and/or CRP ≥3.0 mg/dL, prolonged PR interval |
Low-risk = ARF incidence <2/100,000 school-aged children/year or RHD prevalence ≤1/1000/year
Lab findings: Elevated ESR/CRP, normochromic normocytic anemia, leukocytosis, prolonged PR interval on ECG.
Treatment
1. Eradication of GAS (Primary Treatment)
- Benzathine penicillin G 1.2 million units IM (single dose) - preferred
- Oral penicillin V 250 mg BID x 10 days (alternative)
- Oral macrolide (e.g., azithromycin) if penicillin-allergic
2. Anti-inflammatory Therapy
| Symptom | Drug | Dose |
|---|
| Arthritis/fever | Aspirin (first-line) | 80-100 mg/kg/day divided; max 4-8 g/day |
| Arthritis/fever | Naproxen (alternative) | 10-20 mg/kg/day divided BID |
| Severe carditis | Corticosteroids (prednisone) | Used for severe carditis/HF; taper after 2-3 weeks |
| Chorea | Carbamazepine or valproate | Haloperidol if severe |
Continue NSAIDs for at least 1 month (or until inflammatory markers normalize). Aspirin response is typically rapid - lack of response should prompt reconsideration of diagnosis.
3. Secondary Prophylaxis (CRITICAL - prevents recurrence and RHD)
- Benzathine penicillin G 1.2 million units IM every 4 weeks (or every 3 weeks in high-risk patients)
- Alternative: oral penicillin V 250 mg BID or oral macrolide
Duration of prophylaxis:
| Category | Duration |
|---|
| ARF without carditis | 5 years or until age 21 (whichever is longer) |
| ARF with carditis, no residual RHD | 10 years or until age 21 |
| ARF with carditis + residual RHD | ≥10 years or until age 40 (sometimes lifelong) |
Key Points
- The arthritis of ARF is never radiographically destructive (unlike RA)
- "Loves the joints, licks the heart" - arthritis is transient; cardiac damage is cumulative with each recurrence
- Sydenham's chorea stops during sleep (distinguishes from tics)
- Subclinical carditis (echocardiographic only) was added to the 2015 revised Jones criteria
- The NSAIDs work so well for arthritis that prompt response is virtually diagnostic; if no response to NSAIDs, reconsider diagnosis
- Jaccoud's arthropathy (non-erosive, deforming) can occur after multiple recurrent articular attacks
Recent evidence (2024-2025): A
Cochrane systematic review (PMID 39312290) confirmed long-term benzathine penicillin G prophylaxis is effective for preventing recurrence and progression to rheumatic heart disease. A
2025 meta-analysis (PMID 40333929) examined severe adverse reactions to benzathine penicillin G - the overall risk of severe reactions is low, supporting its continued use for prophylaxis.
- Goldman-Cecil Medicine, International Edition (2-Vol Set)
- Firestein & Kelley's Textbook of Rheumatology, 2-Volume Set